Results 61 to 70 of about 17,098 (226)

Association of Vitamin D Levels and Mortality in Overactive Bladder: Nonlinear Dose–Response and Threshold Effect

open access: yesFood Science &Nutrition, Volume 14, Issue 4, April 2026.
This study investigated the association between serum 25‐hydroxyvitamin D [25(OH)D] levels and mortality risk in 4681 patients with overactive bladder (OAB) from the 2005 to 2018 NHANES cohort. Restricted cubic spline analysis revealed a non‐linear dose–response relationship, namely an L‐shaped association with all‐cause mortality (threshold: 66.82 ...
Chao Yang   +6 more
wiley   +1 more source

Vitamin D supplementation does not improve human skeletal muscle contractile properties in insufficient young males [PDF]

open access: yes, 2014
Vitamin D may be a regulator of skeletal muscle function, although human trials investigating this hypothesis are limited to predominantly elderly populations.
Close, Graeme L   +7 more
core   +1 more source

Renal function in children with hypercalciuria

open access: yesThe Turkish Journal of Pediatrics, 1997
Hypercalciuria is a common problem causing symptoms such as abdominal pain, hematuria and enuresis, and leading to stone formation. It results from a renal tubular calcium "leak" or intestinal hyper-reabsorption of calcium.
N Tekin, N Kural, M Torun
doaj  

CHRONIC RENAL FAILURE DUE TO FAMILIAL HYPOMAGNESEMIC HYPERCALCIURIA (A CASE REPORT)

open access: yesTurkish Journal of Nephrology, 2019
Familial Hypomagnesemia- hypercalciuria is a hereditary disease of unknown etiology characterized by persistant Hypomagnesemia, incomplete distal tubuler acidosis, hypercalciuria and nephrocalcinosis.
Ali Rıza ODABAŞ   +4 more
doaj  

Vitamin D receptor gene polymorphisms in children with kidney stone disease

open access: yesThe Turkish Journal of Pediatrics, 2017
Kidney stone disease has a multifactorial etiology involving the interaction of genetic and environmental factors. There is an increased risk of stone formation in the relatives of idiopathic stone patients, which can be explained up to 60% by genetic ...
Berivan Subaşı   +3 more
doaj   +1 more source

Identifying recurrent stone formers with machine learning: A single‐centre observational study

open access: yesBJUI Compass, Volume 7, Issue 3, March 2026.
Abstract Objectives Kidney stones affect 12% of the population over their lifetime. Recurrent kidney stones lead to repeated interventions and excessive healthcare costs. Despite progress in imaging and metabolic evaluations, models to accurately identify patients at high risk are missing.
Pedro Amado   +7 more
wiley   +1 more source

Accuracy of urine pH testing in a regional metabolic renal clinic: is the dipstick accurate enough? [PDF]

open access: yes, 2013
Urine pH is a useful marker for assessing treatment need and efficacy in patients with nephrolithiasis. Though the gold standard of measurement is with a pH electrode, dipsticks offer the convenience of cost, ease of use, and the possibility of patients ...
Caroline Robinson   +4 more
core   +1 more source

Hypercalciuria and nephrocalcinosis in cystic fibrosis patients

open access: yesThe Turkish Journal of Pediatrics, 2004
The objective of this study was to determine the frequency of nephrocalcinosis and hypercalciuria in cystic fibrosis (CF) patients, and to search possible causes of this phenomenon. Forty-three CF children (24 boys, 19 girls; mean age 64.9 months,
Uğur Ozçelik   +6 more
doaj  

Investigating the Prevalence of Hypercalciuria in Children Aged 2–16 Years With Asymptomatic Microscopic Hematuria in 2020 in Tehran Children's Medical Center

open access: yesClinical Case Reports
The prevalence of hypercalciuria in children is 3%–10% globally and up to 35% in the United States. Hypercalciuria in children has many presentations; it causes different metabolic disorders and can negatively affect a child's growth.
Izat MohammadKhawajah   +4 more
doaj   +1 more source

Impact of Thiazides and Fluoropyrimidines Interaction on Myelotoxicity and Other Adverse Events in Real‐World Practice: A Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Introduction The European Summary of Product Characteristics (SmPC) for 5‐FU warns of significant granulocyte decline when combined with thiazides, cyclophosphamide, or methotrexate, based on a 1981 cohort of 14 patients. Despite limited evidence, drug‐interaction checkers still flag this risk.
Gerard Ronda‐Roca   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy